Xeris Biopharma Holdings is a pharmaceutical company based in Chicago that develops and commercialises injectable medicines. It uses its own formulation technologies to make drugs that can be given by injection, including ready-to-use liquid forms of treatments that were previously supplied as powders needing mixing. Its products serve patients with endocrine and neuromuscular conditions, and it also works with other drug developers who use its formulation platforms for their own medicines.
Xeris Biopharma Holdings, Inc. trades under the code 0A8E on the London Exchange in UK, with its price quoted in US dollars (USD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Fair price profile
Ranks #897 of 3787 on the London Exchange · confidence Medium
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendStrong
96/100
Trading above its long-term averages and near its highs.
See the numbers →
Above 200-day average53.3%
From 52-week high0.0%
MomentumStrong
95/100
Rising faster than most stocks on this exchange.
See the numbers →
3-month return28.5%
6-month return92.9%
Stability (higher is calmer)Weak
32/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)51.9%
Worst drawdown, 1 year (smaller is calmer)-35.4%
LiquidityWeak
20/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.03M USD
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 5.26 – 11.38Daily closes, split-adjusted
Signals
50-day average8.92
200-day average7.36
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.45
Technical summary
Daily
Bullish
11 bullish · 0 neutral · 4 bearish
Weekly
Strongly bullish
6 bullish · 0 neutral · 1 bearish
Monthly
Strongly bullish
1 bullish · 0 neutral · 0 bearish
Moving averages (daily)
SMA 10
10.31
Bullish
EMA 10
10.24
Bullish
SMA 20
9.77
Bullish
EMA 20
9.82
Bullish
SMA 50
8.92
Bullish
EMA 50
9.10
Bullish
SMA 100
8.29
Bullish
EMA 100
8.44
Bullish
SMA 200
7.36
Bullish
EMA 200
–
n/a
Oscillators (daily)
RSI (14)
73.07
Bearish
MACD (12, 26)
0.53
Bullish
Momentum (12)
21.28
Bullish
Stochastic %K (14)
96.37
Bearish
Williams %R (14)
-3.63
Bearish
CCI (20)
158.5
Bearish
Pivot points (classic, last session)
S3
9.63
S2
10.00
S1
10.64
Pivot
11.01
R1
11.66
R2
12.02
R3
12.67
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in USD. Educational only, not financial advice.
